Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

European School of Haematology (ESH) meeting: International Conference on Acute Lymphoblastic Leukaemia 2019 (ICALL)

17 - 19 May 2019
Vienna House Andels' Berlin Hotel, Berlin, Germany
Novel adoptive cell therapies for acute lymphoblastic leukaemia
Prof Rupert Handgretinger, Director and Chair, Children’s University Hospital an...
Novel adoptive cell therapies for acute lymphoblastic leukaemia ( Prof Rupert Handgretinger, Director and Chair, Children’s University Hospital and Department of Haematology/Oncology, Tübingen, Germany )
24 May 2019
Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse
Prof David Marks - University Hospital Bristol, Bristol, UK
Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse ( Prof David Marks - University Hospital Bristol, Bristol, UK )
24 May 2019
CNS involvement and prophylaxis in acute lymphoblastic leukaemia
Dr Mark Litzow - Mayo Clinic, Rochester, USA
CNS involvement and prophylaxis in acute lymphoblastic leukaemia ( Dr Mark Litzow - Mayo Clinic, Rochester, USA )
24 May 2019
Indications for allogeneic haematopoietic stem cell transplantation in adult acu...
Dr Mark Litzow - Mayo Clinic, Rochester, USA
Indications for allogeneic haematopoietic stem cell transplantation in adult acute lymphoblastic leukaemia ( Dr Mark Litzow - Mayo Clinic, Rochester, USA )
24 May 2019
Metabolic vulnerability in NOTCH-driven T cell acute lymphoblastic leukaemia
Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK
Metabolic vulnerability in NOTCH-driven T cell acute lymphoblastic leukaemia ( Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK )
24 May 2019
MLL-rearranged acute lymphoblastic leukaemia
Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain
MLL-rearranged acute lymphoblastic leukaemia ( Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain )
24 May 2019
Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphob...
Prof Max Topp - University of Würzburg, Würzburg, Germany
Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphoblastic leukaemia ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
24 May 2019
MRD management in adults with acute lymphoblastic leukaemia
Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy
MRD management in adults with acute lymphoblastic leukaemia ( Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy )
24 May 2019
Using CAR T cells for the treatment of acute lymphoblastic leukaemia
Prof Claudia Rossig - Universität Münster, Münster, Germany
Using CAR T cells for the treatment of acute lymphoblastic leukaemia ( Prof Claudia Rossig - Universität Münster, Münster, Germany )
24 May 2019
Optimal use of tyrosine kinase inhibitors as a treatment for Philadelphia chromo...
Prof Hervé Dombret, University Paris Diderot, Paris, France
Optimal use of tyrosine kinase inhibitors as a treatment for Philadelphia chromosome-positive acute lymphoblastic leukaemia ( Prof Hervé Dombret, University Paris Diderot, Paris, France )
24 May 2019
Highlights from ICALL 2019
Prof Hervé Dombret - University Paris Diderot, Paris, France
Highlights from ICALL 2019 ( Prof Hervé Dombret - University Paris Diderot, Paris, France )
24 May 2019
Precision diagnosis for tailored therapy in acute lymphoblastic leukaemia
Dr Jean-Pierre Bourquin - University Children’s Hospital, Zurich, Switzerland
Precision diagnosis for tailored therapy in acute lymphoblastic leukaemia ( Dr Jean-Pierre Bourquin - University Children’s Hospital, Zurich, Switzerland )
24 May 2019
Integrating, balancing and disregarding risk factors in paediatric acute lymphob...
Prof Anthony Moorman - Newcastle University, Newcastle, UK
Integrating, balancing and disregarding risk factors in paediatric acute lymphoblastic leukaemia ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )
24 May 2019
Epigenetic expression in T cell leukaemia
Dr Sinisa Dovat - Penn State Cancer Institute, Hershey, USA
Epigenetic expression in T cell leukaemia ( Dr Sinisa Dovat - Penn State Cancer Institute, Hershey, USA )
24 May 2019
Managing metabolism and drug toxicity in acute lymphoblastic leukaemia
Dr Mary Relling - St Jude's Children's Research Hospital, Memphis, USA
Managing metabolism and drug toxicity in acute lymphoblastic leukaemia ( Dr Mary Relling - St Jude's Children's Research Hospital, Memphis, USA )
24 May 2019
B-lymphoid transcriptional programme as a barrier against malignant transformati...
Prof Markus Müschen - City of Hope Comprehensive Cancer Center, Los Angeles, USA
B-lymphoid transcriptional programme as a barrier against malignant transformation in acute lymphoblastic leukaemia ( Prof Markus Müschen - City of Hope Comprehensive Cancer Center, Los Angeles, USA )
24 May 2019
Individual management of acute lymphoblastic leukaemia in adolescents and young ...
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
Individual management of acute lymphoblastic leukaemia in adolescents and young adults ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )
24 May 2019
Master pathways and targets in T cell acute lymphoblastic leukaemia
Prof Jean Soulier - Hôpital Saint Louis, Paris, France
Master pathways and targets in T cell acute lymphoblastic leukaemia ( Prof Jean Soulier - Hôpital Saint Louis, Paris, France )
24 May 2019
T cell development and T cell leukaemia
Prof Hans-Reimer Rodewald - Universitätsklinikum Heidelberg, Heidelberg, Germany
T cell development and T cell leukaemia ( Prof Hans-Reimer Rodewald - Universitätsklinikum Heidelberg, Heidelberg, Germany )
24 May 2019